Mortality from testicular cancer has been declining in the USA since the 1970's and in western Europe since the late 1970's, and the rates in the late 1990's were about 70% lower than in the 1970's. In Eastern Europe, however, some decline was observed only since the late 1980's and was substantially smaller (only approximately 20%). Consequently, a few hundred avoidable deaths from a curable neoplasm, mainly of young adults, are still registered in Eastern Europe. This underlines the urgency of implementation of available and effective therapeutic schemes for testicular cancer in Eastern Europe.